On Friday, April 15, 2016, the Nonprescription Drugs Advisory Committee (NDAC) unanimously supported, by a vote of 16-Yes to 0-No, with no abstentions, the over-the-counter (OTC) marketing of Differin (adapalene gel 0.1%) by Galderma Laboratories, L.P. (Galderma) for the treatment of acne in consumers ages 12 years and older.